George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,064.00
Bid: 1,056.00
Ask: 1,064.00
Change: 12.00 (1.14%)
Spread: 8.00 (0.758%)
Open: 1,056.00
High: 1,078.00
Low: 1,056.00
Prev. Close: 1,052.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

17 May 2023 07:00

RNS Number : 6286Z
Savills PLC
17 May 2023
 

 

17 May 2023

SAVILLS PLC

("Savills" or "the Company")

Trading update

 

Ahead of its Annual General Meeting (AGM) to be held at 12 noon today at Savills, 33 Margaret Street, London W1G 0JD, Savills plc, the international real estate advisor issues the following trading update:

 

· As capital values progressively adjust to higher interest rates global capital transaction volumes for the year to date are at the lowest levels seen for a decade; this has clearly impacted the Group's Commercial transaction business in the early part of the year.

· Leasing markets have remained more resilient across most sectors, although office take up is heavily skewed to prime stock with strong sustainability credentials.

· Although volumes are lower than last year, as expected, prime residential markets have performed well with a particular emphasis on the London market.

· Sentiment in China has improved significantly since the end of COVID restrictions, albeit this has yet to show materially in the Group's revenue line.

· Savills less transactional businesses have performed in line with expectations.

· H1 2023 will be materially impacted by the ongoing recalibration of global investment markets; and whilst the range of potential outcomes for the year as a whole has widened since year-end, we continue to expect progressive improvement in the second half of the year as markets start to recover.

 

Mark Ridley, Group Chief Executive, commented:

 

"During this period of adjustment, I am delighted with the response of our people both in helping clients facing challenging circumstances and in seeking longer term business development initiatives, which our strong balance sheet enables us to pursue at this opportune time. The strength of our less transactional businesses has helped underpin the Group's performance overall. The anticipated market corrections in 2023 are happening largely as anticipated. As greater certainty over the future pattern of global interest rates is emerging, we expect progressive recovery through the third and fourth quarters of the year and into 2024."

 

Trading Update

 

In the Asia Pacific region, Japan and Korea have traded well and sentiment in mainland China has significantly improved since the New Year. Elsewhere, markets are correcting to the prevailing level of interest rates. Our substantial Property and Facilities Management business in the region continues to perform well.

 

In the UK, our performance has been largely in line with expectations, driven primarily by the good levels of activity in the prime residential markets and some recovery in retail. Other commercial capital markets have been severely impacted as pricing adjusts, however we have enjoyed an unusually high market share in prime transactional markets, which has partially mitigated the significant decline in volumes. Partly because post-Brexit, UK yields did not compress as far as other international markets, we believe that prime real estate valuations have largely corrected and we await improving sentiment into which to launch a very attractive pipeline. Our less transactional service lines have performed in line with our expectations to date.

 

In Continental Europe and the Middle East, where Savills is highly dependent upon transactional activity, volumes, particularly in the major markets of Germany and France, have been severely reduced during the period. Leasing momentum remains subdued and across capital markets, yields have moved out considerably, and the correction, although not yet complete, is well underway. This has had a significant impact on our business in the year to date.

 

In North America, where the Group is substantially dependent upon leasing activity by corporate occupiers, our business performance has been in line with our expectations, albeit individual transaction sizes are currently much reduced.

 

Savills Investment Management has traded in line with our expectations. In an environment which remains challenging for the deployment of equity capital and valuations adjust to prevailing debt costs, our business has experienced the expected impact on both base management and performance fees during the period.

 

Summary and Outlook

 

In the year to date, global commercial investment volumes have either reached or approached their lowest levels in many years. As a result, at this early stage, the range of outcomes for the year as a whole has widened, however our prime commercial leasing, residential, consultancy and property management businesses all continue to trade in line with expectations.

 

Although it is impossible accurately to predict the timing of individual market recoveries, we remain optimistic that markets will start to improve in the second half and we are seeing early signs of this in some areas. Confidence in the ongoing recovery and level of transactional velocity through the latter part of the year will be key to supporting our view that 2024 will show transaction volume growth in most markets. In the meantime, we continue to pursue opportunities to develop our business both through targeted recruitment and selective acquisition.

 

We anticipate announcing the Group's Half Year Results for the six months to 30 June on 10 August 2023.

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive Officer

Simon Shaw, Group Chief Financial Officer

 

Teneo 020 7353 4200

Mark Burgess

Will Palfreyman

Jo Blackshaw

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFLREEIRLIV
Date   Source Headline
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding
1st Feb 202411:00 amRNSTotal Voting Rights
22nd Jan 20249:11 amRNSBlock listing Interim Review
11th Jan 20244:02 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNSYear End Trading Update
2nd Jan 202412:33 pmRNSTotal Voting Rights
15th Dec 202310:00 amRNSAdditional Listing
14th Dec 202312:56 pmRNSDirector/PDMR Shareholding
13th Dec 202311:42 amRNSNon-Executive Director Appointment
13th Nov 20232:02 pmRNSSAVILLS APPOINTS NEW CEO OF SAVILLS NORTH AMERICA
13th Nov 202312:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20233:16 pmRNSForm 8.3 - OntheMarket PLC
1st Nov 202310:00 amRNSTotal Voting Rights
27th Oct 202310:00 amRNSAdditional Listing
12th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20238:50 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSAdditional Listing
12th Sep 20235:10 pmRNSTotal Voting Rights
1st Sep 202311:00 amRNSTotal Voting Rights
18th Aug 20232:00 pmRNSAdditional Listing
15th Aug 20234:06 pmRNSBlock listing Interim Review
14th Aug 20232:05 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSChair Succession
10th Aug 20237:00 amRNSHalf-year Report
21st Jul 202310:00 amRNSBlock listing Interim Review
11th Jul 202312:50 pmRNSDirector/PDMR Shareholding
4th Jul 20239:20 amRNSTotal Voting Rights
13th Jun 20235:31 pmRNSDirector/PDMR Shareholding
1st Jun 202310:00 amRNSTotal Voting Rights
17th May 20234:05 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Statement
11th May 20236:12 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20235:15 pmRNSDirector/PDMR Shareholding
12th Apr 20232:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:15 pmRNSAnnual Report and AGM Notice
30th Mar 20237:47 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.